ABBV

AbbVie Inc.NYSEHealthcare

$208.79-2.88%OpenMarket Cap: $369.19B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-18	Piper Sandler	—	Overweight	—
2026-02-17	Freedom Broker	—	Buy	—
2026-02-05	Morgan Stanley	—	Overweight	—
2026-02-05	UBS	—	Neutral	—
2026-02-05	Evercore ISI Group	—	Outperform	—
2026-01-27	Citigroup	—	Neutral	—
2026-01-08	Wolfe Research	—	Peer Perform	—
2025-12-12	Morgan Stanley	—	Overweight	—
2025-12-10	HSBC	—	Buy	—
2025-11-12	Freedom Broker	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$16.19	$72.31B	18
Sun Dec 31	$17.87	$77.59B	12
Mon Dec 31	$19.55	$81.74B	10
Tue Dec 31	$20.05	$83.44B	5